Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesEfficacy of glucantime in the treatment of Old World cutaneous leishmaniasis
International Journal of Dermatology, 06/23/09
Firdous R et al. - Glucantime is still effective against Old World cutaneous leishmaniasis when used in the doses recommended by WHO.
Related Articles
Cutaneous leishmaniasis treated with itraconazole
Dermatologic Therapy, 11/20/09
Relevance Score: 85%
Cutaneous and mucocutaneous leishmaniasis
Dermatologic Therapy, 11/20/09
Relevance Score: 85%
Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review
Parasite Immunology, 10/26/09
Relevance Score: 85%
Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent
Tropical Medicine & International Health, 11/17/09
Relevance Score: 84%
Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09
Relevance Score: 84%
Today in Derm Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinically relevant drug interactions of current antifungal agents
Mycoses, 12/15/09
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/15/09
Molecular analysis of the cutaneous Malassezia microbiota from the skin of patients with atopic dermatitis of different severities
Mycoses, 12/15/09
Article Search
Sponsor